US 8183274
Treatment of hyperproliferative disorders with diarylhydantoin compounds
granted A61PA61P13/08A61P17/10
Quick answer
US patent 8183274 (Treatment of hyperproliferative disorders with diarylhydantoin compounds) held by The Regents of the University of California expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P13/08, A61P17/10, A61P17/14, A61P35/00